Related Experiment Video
Updated: Apr 14, 2026
12:25
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
16.7K
Infant botulism: review and clinical update
Laura K Rosow1, Jonathan B Strober2
1Department of Neurology, University of California San Francisco, San Francisco, California.
Pediatric Neurology
|April 18, 2015
Summary
Infant botulism, a rare neuromuscular illness in infants under one, is effectively treated with intravenous botulism immunoglobulin (BIG-IV). This treatment significantly reduces illness severity and healthcare expenses.
Area of Science:
- Neurology
- Pediatrics
- Infectious Diseases
Background:
- Infant botulism is a rare neuromuscular condition caused by Clostridium botulinum spores.
- First identified in the 1970s, it primarily affects infants under one year of age.
- The condition poses significant health risks and associated hospital costs.
Purpose of the Study:
- To review the pathogenesis of infant botulism.
- To detail the epidemiology, clinical manifestations, and diagnosis of infant botulism.
- To discuss the established treatment for infant botulism.
Main Methods:
- Literature review of infant botulism.
- Analysis of epidemiological data.
- Review of clinical case studies and treatment outcomes.
Main Results:
- Intravenous botulism immunoglobulin (BIG-IV or BabyBIG®), developed in 2003, is a specific treatment for infant botulism.
- BIG-IV has substantially decreased morbidity and hospital costs associated with infant botulism.
- Understanding pathogenesis, epidemiology, and clinical features aids diagnosis and management.
Conclusions:
- Infant botulism requires specific diagnostic and treatment approaches.
- Early diagnosis and treatment with BIG-IV are crucial for improving infant outcomes.
- Continued research into rare neuromuscular conditions like infant botulism is important.
Related Concept Videos
01:26Esophageal Strictures-II: Clinical Features and Management
1000
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
1000
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
1.2K
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
1.2K
01:30Development of Human Microbiota
49
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
49
01:29Drug Dosing: Infants and Children
886
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
886
01:30Pneumonia V: Nursing management and Prevention
4.1K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.1K
01:25Clinical Significance of Antibiotic Resistance
57
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
57